Obesity Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

1. Executive Summary: Obesity
   • Global Market Outlook: Obesity
2. Competitive Intelligence Analysis: Obesity
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Obesity
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Disease Overview: Obesity
   • Disease Etiology
   • Pathophysiology
   • Risk Factors
   • Treatment Algorithm
7. Obesity: Key Marketed Products Profile – Major Approved Products
   • Product Profile
   • Regulatory Milestones
   • Safety and Efficacy
   • Clinical Development
8. Obesity: Promising Pipeline Candidates – Major Products in Late Stage of Development
   • Product Description
   • Safety and Efficacy
   • Research and Development
9. Regulatory Landscape
10. Obesity: Eight Major Market (8MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
11. S. Obesity – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
12. K. Obesity – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
13. Germany Obesity – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
14. France Obesity – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
15. Italy Obesity – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
16. Spain Obesity – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
17. Japan Obesity – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
18. China Obesity – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
19. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

20. Assumptions and Acronyms Used
21. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
22. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, and China

Copyrights and Disclaimer

Obesity Market – Report Overview

Pacific Business Consulting’s “Obesity Market in 8MM – Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)” report offers a comprehensive understanding of Obesity, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Eight Major Markets (8MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and China.

The obesity market size across the Eight Major Markets (8MM) was valued at US$2.15 billion in 2022 and is expected to achieve a double-digit Compound Annual Growth Rate (CAGR) during the forecast period from 2022 to 2030. The United States is anticipated to account for nearly 75% of the global market due to its large population, higher drug prices, and consistently high treatment rates. However, the U.S. is expected to experience the slowest growth during the forecast period.

Obesity is defined as an abnormal or excessive accumulation of fat or adipose tissue in the body that poses a risk to health. The Body Mass Index (BMI) is used to define obesity, calculated as weight (kg)/height (m^2), with a BMI greater than or equal to 30 considered obese. Obesity is associated with various health risks, including cardiovascular disease, diabetes mellitus, respiratory problems, psychological issues, hypertension, obstructive sleep apnea, cancer, and hyperlipidemia.

Some major drivers of growth in the obesity market across the 8MM over the forecast period include the entry of therapies with new routes of administration, such as Pfizer’s PF-07081532, danuglipron tromethamine, Eli Lilly’s orforglipron, and Novo Nordisk’s oral semaglutide. Greater awareness of obesity as a disease, rather than a lifestyle choice, is expected to create an environment favoring convenient, efficacious therapies that can improve patient compliance rates and facilitate higher percentage weight loss in obese patients.

Leading companies in the obesity market include Eli Lilly and Company, Novo Nordisk, MedImmune, Raziel Therapeutics, Boehringer Ingelheim, Altimmune, YSOPIA Bioscience, Saniona, Innovent Biologics, Shionogi, Aardvark Therapeutics, Glaceum, Novartis, CSPC Baike, and NuSirt Biopharma.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Obesity market. It also delves into the analysis of present and prospective market competition within the global Obesity market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Obesity market across the 8MM (Eight Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 8MM Obesity market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Please note that detailed pipeline analysis can be provided along with the standard scope to assist you in developing and designing your in-licensing and out-licensing strategies. This includes a review of pipeline products and technologies, along with identifying companies with the most robust pipeline.